The long and short of chromosome 11 in breast cancer.
作者信息
Newsham I F
机构信息
Department of Anatomy, Medical College of Virginia at Virginia Commonwealth University, Richmond 23298, USA.
出版信息
Am J Pathol. 1998 Jul;153(1):5-9. doi: 10.1016/S0002-9440(10)65538-1.
Abstract
摘要
相似文献
1
The long and short of chromosome 11 in breast cancer.乳腺癌中11号染色体的要点
Am J Pathol. 1998 Jul;153(1):5-9. doi: 10.1016/S0002-9440(10)65538-1.
2
Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma.人类乳腺癌中13号和17号染色体上选择位点的杂合性缺失。
Anticancer Res. 1991 Jul-Aug;11(4):1501-7.
3
Cytogenetic analysis of metastatic effusions from breast tumors.
Neoplasma. 1989;36(1):71-81.
4
Genetic alteration mapping on chromosome 7 in primary breast cancer.原发性乳腺癌7号染色体上的基因改变图谱
Clin Cancer Res. 1997 Jun;3(6):1009-16.
5
[Demonstration of two regions involved in chromosome 1p deletion in breast tumors].
Bull Cancer. 1994 Feb;81(2):108-13.
6
Two distinct regions involved in 1p deletion in human primary breast cancer.人类原发性乳腺癌中1p缺失所涉及的两个不同区域。
Cancer Res. 1993 May 1;53(9):1990-4.
7
Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors.人类乳腺肿瘤中11号染色体p15.5区域杂合性缺失的细化
Cancer Res. 1993 Oct 1;53(19):4486-8.
8
[Allelic loss on chromosome 11q13 in male breast cancer].
An R Acad Nac Med (Madr). 1995;112(4):669-77.
9
10
Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression.抑癌基因 PTEN 在乳腺癌中的研究进展：杂合性缺失、突变及蛋白表达
Anticancer Res. 2014 Mar;34(3):1387-400.
引用本文的文献
1
Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma.小叶原位癌缺失是浸润性小叶癌的不良预后标志物。
Eur J Cancer. 2023 Sep;191:113250. doi: 10.1016/j.ejca.2023.113250. Epub 2023 Jul 22.
2
Effects of Human Papilloma Virus E6/E7 Oncoproteins on Genomic Structure in Head and Neck Squamous Cell Carcinoma.人乳头瘤病毒E6/E7癌蛋白对头颈部鳞状细胞癌基因组结构的影响
Cancers (Basel). 2022 Dec 15;14(24):6190. doi: 10.3390/cancers14246190.
3
Chemotherapy Controls Metastasis Through Stimulatory Effects on GRP78 and Its Transcription Factor CREB3L1.化疗通过对GRP78及其转录因子CREB3L1的刺激作用来控制转移。
Front Oncol. 2020 Sep 11;10:1500. doi: 10.3389/fonc.2020.01500. eCollection 2020.
4
Association Analysis of Methylenetetrahydrofolate Reductase Common Gene Polymorphisms with Breast Cancer Risk in an Iranian Population: A Case-Control Study and a Stratified Analysis.亚甲基四氢叶酸还原酶常见基因多态性与伊朗人群乳腺癌风险的关联分析：病例对照研究和分层分析。
Asian Pac J Cancer Prev. 2020 Sep 1;21(9):2709-2714. doi: 10.31557/APJCP.2020.21.9.2709.
5
Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.DNA甲基化导致的CREB3L1表观遗传沉默与预后不良的高级别转移性乳腺癌相关，且在三阴性乳腺癌中普遍存在。
Breast Cancer Res. 2016 Jan 25;18(1):12. doi: 10.1186/s13058-016-0672-x.
6
miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.微小RNA-34a通过沉默c-SRC来减弱三阴性乳腺癌的肿瘤生长
Cancer Res. 2016 Feb 15;76(4):927-39. doi: 10.1158/0008-5472.CAN-15-2321. Epub 2015 Dec 16.
7
Phospho-histone H2AX is a diagnostic and prognostic marker for epithelial ovarian cancer.磷酸化组蛋白H2AX是上皮性卵巢癌的一种诊断和预后标志物。
Int J Clin Exp Pathol. 2015 May 1;8(5):5597-602. eCollection 2015.
8
miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention.miR-24-2 通过靶向抗凋亡基因 BCL-2 控制 H2AFX 的表达，而与基因拷贝数改变无关，并诱导细胞凋亡：一种潜在的治疗干预靶点。
Breast Cancer Res. 2011 Apr 4;13(2):R39. doi: 10.1186/bcr2861.
9
Significance of lobular intraepithelial neoplasia at margins of breast conservation specimens: a report of 38 cases and literature review.乳腺保乳标本切缘的小叶内上皮内瘤变的意义：38 例报告及文献复习。
Diagn Pathol. 2010 Aug 20;5:54. doi: 10.1186/1746-1596-5-54.
10
Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.接受对侧预防性乳房切除术的单侧乳腺癌患者对侧乳腺癌的预测因素。
Cancer. 2009 Mar 1;115(5):962-71. doi: 10.1002/cncr.24129.
本文引用的文献
1
Loss of heterozygosity in lobular carcinoma in situ of the breast.乳腺小叶原位癌中的杂合性缺失
Clin Mol Pathol. 1995 Apr;48(2):M74-8. doi: 10.1136/mp.48.2.m74.
2
Loss of heterozygosity on chromosome 11p15 during histological progression in microdissected ductal carcinoma of the breast.乳腺微切割导管癌组织学进展过程中11号染色体p15区域杂合性缺失
Am J Pathol. 1998 Jul;153(1):271-8. doi: 10.1016/S0002-9440(10)65568-X.
3
Multistep carcinogenesis of breast cancer and tumour heterogeneity.
J Mol Med (Berl). 1997 Jun;75(6):429-39. doi: 10.1007/s001090050128.
4
Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction.利用组织显微切割和聚合酶链反应检测乳腺小叶病变中11q13染色体杂合性缺失
Hum Pathol. 1997 Mar;28(3):277-82. doi: 10.1016/s0046-8177(97)90124-6.
5
Microsatellite alterations indicating monoclonality in atypical hyperplasias associated with breast cancer.微卫星改变表明与乳腺癌相关的非典型增生中的单克隆性。
Hum Pathol. 1997 Feb;28(2):214-9. doi: 10.1016/s0046-8177(97)90109-x.
6
7
Cancer statistics, 1997.1997年癌症统计数据。
CA Cancer J Clin. 1997 Jan-Feb;47(1):5-27. doi: 10.3322/canjclin.47.1.5.
8
Loss of heterozygosity in normal tissue adjacent to breast carcinomas.乳腺癌旁正常组织中的杂合性缺失
Science. 1996 Dec 20;274(5295):2057-9. doi: 10.1126/science.274.5295.2057.
9
Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.乳腺导管原位癌的基因进展、组织学分级及等位基因缺失
Cancer Res. 1996 Nov 15;56(22):5260-5.
10
Genetics and malignant progression of human brain tumours.人类脑肿瘤的遗传学与恶性进展
Cancer Surv. 1995;25:233-75.
Zotero 插件